Loading clinical trials...
Loading clinical trials...
Phase II Study of Pemetrexed + Cetuximab + Cisplatin With Concurrent Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
Conditions
Interventions
Chemotherapy
ERBITUX
+1 more
Locations
38
France
Clinique de l'Europe
Amiens, France
Centre Hospitalier
Annemasse, France
CHU Besancon - Pneumologie
Besançon, France
Bordeaux - Polyclinique Nord
Bordeaux, France
Caen - Centre François Baclesse
Caen, France
Caen - CHU Côte de Nacre
Caen, France
Start Date
March 1, 2010
Primary Completion Date
January 1, 2014
Completion Date
December 1, 2015
Last Updated
February 16, 2021
NCT01993810
NCT03154190
NCT03492801
NCT03455556
NCT04111913
NCT03077854
Lead Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions